Geneos Wealth Management’s Stellus Capital Investment Corp SCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,798
Closed -$23.5K – 2545
2025
Q3
$23.5K Hold
1,798
– – ﹤0.01% 1667
2025
Q2
$25.1K Buy
+1,798
New +$23.8K ﹤0.01% 1922
2022
Q3
– Sell
-1,390
Closed -$15K – 2493
2022
Q2
$15K Hold
1,390
– – ﹤0.01% 1818
2022
Q1
$19K Sell
1,390
-1,798
-56% -$24.5K ﹤0.01% 1832
2021
Q4
$41K Hold
3,188
– – ﹤0.01% 1562
2021
Q3
$41K Hold
3,188
– – ﹤0.01% 1582
2021
Q2
$41K Hold
3,188
– – ﹤0.01% 1581
2021
Q1
$42K Buy
3,188
+640
+25% +$7.33K ﹤0.01% 1723
2020
Q4
$32K Hold
2,548
– – ﹤0.01% 1677
2020
Q3
$21K Hold
2,548
– – ﹤0.01% 1637
2020
Q2
$18K Hold
2,548
– – ﹤0.01% 1671
2020
Q1
$20K Sell
2,548
-1,000
-28% -$12.5K ﹤0.01% 1518
2019
Q4
$51K Hold
3,548
– – ﹤0.01% 1247
2019
Q3
$49K Buy
3,548
+1,798
+103% +$24.7K ﹤0.01% 1196
2019
Q2
$24K Hold
1,750
– – ﹤0.01% 1553
2019
Q1
$24K Buy
+1,750
New +$24.8K ﹤0.01% 1489

Other funds holding SCM

Geneos Wealth Management's SCM Position: Q4 2025 in Review

Geneos Wealth Management sold out of Stellus Capital Investment Corp (SCM) in Q4 2025, closing a stake of 1,798 shares — an estimated $23.5K sold.

Geneos Wealth Management first reported a position in SCM in Q1 2019 and held it in 16 quarters. The position peaked at $51K in Q4 2019. 63 funds tracked by Wall St. Rank hold SCM as of Q4 2025.

  • Geneos Wealth Management reported no remaining Stellus Capital Investment Corp position as of Q4 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 1,798 Stellus Capital Investment Corp shares in Q4 2025, an estimated $23.5K.
  • Geneos Wealth Management first reported a position in Stellus Capital Investment Corp in Q1 2019 and held it in 16 quarters.
  • Geneos Wealth Management's Stellus Capital Investment Corp position peaked at $51K in Q4 2019.
  • 63 funds tracked by Wall St. Rank held Stellus Capital Investment Corp as of Q4 2025.

Based on Geneos Wealth Management's 13F filing for Q4 2025, filed 28 Jan 2026.